New screening strategy aims to catch heart failure risk early in diabetes patients
NCT ID NCT06593327
First seen Mar 06, 2026 · Last updated Jun 22, 2026 · Updated 20 times
Summary
This study tests a heart failure screening strategy for people with type 2 diabetes. Doctors use a blood test (NT-proBNP) and a risk score to identify high-risk patients, then recommend preventive treatments. The trial involves 300 patients and their primary care providers. The goal is to see if this approach reduces heart failure and death.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75209, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this screening strategy could help doctors identify diabetes patients at high risk for heart failure earlier and start preventive treatments sooner.
What could go wrong
This is a small, early-stage study focused on screening, not a treatment trial. It may not show a clear reduction in heart failure or death, and results may not apply to all diabetes patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.